Evidence map›Paper›PMID 41726701›Full record

ArticleACS omega2026

Investigation of Ag-ZnO/rGO Hybrid Composite Material as a Photocatalyst for Phenol Degradation in Aqueous Systems.

Tanawat Imboon, K Hemkumar, Jeerawan Khumphon, Chaisak Issro, Jarinee Kiang-Ia, Viyaporn Krongtong, Veeramani Mangala Gowri, Sirikanjana Thongmee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tanawat ImboonDepartment of Physics, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.ORCID https://orcid.org/0009-0000-7388-8854
K HemkumarDepartment of Chemical Engineering, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India.ORCID https://orcid.org/0000-0003-4482-9999
Jeerawan KhumphonDepartment of Physics, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.
Chaisak IssroDepartment of Physics, Faculty of Science, Burapha University, Chonburi 10131, Thailand.
Jarinee Kiang-IaDepartment of Industrial Physics and Medical Instrumentation, Faculty of Applied Science, King Mongkut's University of Technology North Bangkok, Bangkok 10140, Thailand.
Viyaporn KrongtongNational Metal and Materials Technology Center, 114 Thailand Science Park, Paholyothin Rd., Klong 1, KlongLuang, Pathumthani 12120, Thailand.
Veeramani Mangala GowriDepartment of Chemical Engineering, Faculty of Engineering, University of Malaya, 50603 Kuala Lumpur, Malaysia.ORCID https://orcid.org/0000-0003-4627-3699
Sirikanjana ThongmeeDepartment of Physics, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.ORCID https://orcid.org/0000-0001-8294-9997

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to enhance the photocatalytic degradation of phenol under UV light by synthesizing a silver-zinc oxide/reduced graphene oxide (Ag-ZnO/rGO) hybrid composite via a hydrothermal method. Structural and optical characterizations confirmed the successful incorporation of Ag and rGO into the ZnO matrix, leading to improved light absorption and efficient charge separation. Photocatalytic tests revealed that the Ag-ZnO/rGO hybrid composite showed superior activity, degrading 76.16% of phenol in just 12 h, significantly higher than Ag-ZnO (65.66%) and pure ZnO (31.78%). After 24 h, it achieved 98.91% degradation. Kinetic analysis confirmed its enhanced performance, showing the highest pseudo-first-order rate constant (

Identifiers

PMID41726701
PMCPMC12917662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.